Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02917824
Other study ID # 1.533.228
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date November 2016
Est. completion date March 2017

Study information

Verified date September 2019
Source Universidade Federal do Rio Grande do Norte
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Inspiratory muscle training (IMT) can reverse or delay the complications from the deterioration of inspiratory muscle function in asthma. Thus, the IMT has been considered a treatment option for people with asthma. The aim of this study is to investigate the training principles of intensity, specificity and reversibility of IMT in asthmatics.


Recruitment information / eligibility

Status Completed
Enrollment 29
Est. completion date March 2017
Est. primary completion date March 2017
Accepts healthy volunteers No
Gender All
Age group 18 Years to 60 Years
Eligibility Inclusion Criteria:

- Diagnosis of asthma

- Adults (18 - 60 years)

Exclusion Criteria:

- Inability to perform the protocol established by the study

- Others respiratory diseases

- Request for study withdrawal

Study Design


Related Conditions & MeSH terms


Intervention

Device:
High-intensity IMT
30 breaths at 50% of the maximal inspiratory pressure, twice daily for 6 weeks
Low-intensity IMT
30 breaths at 15% of the maximal inspiratory pressure, twice daily for 6 weeks

Locations

Country Name City State
Brazil Gardenia Maria Holanda Ferreira Natal Rio Grande Do Norte

Sponsors (1)

Lead Sponsor Collaborator
Universidade Federal do Rio Grande do Norte

Country where clinical trial is conducted

Brazil, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in inspiratory muscle strength Maximal inspiratory pressure Baseline, 6 weeks later and 6 weeks after training
Primary Change in expiratory muscle strength Maximal expiratory pressure Baseline, 6 weeks later and 6 weeks after training
Secondary Change in asthma control Asthma Control Questionnaire measures the adequacy of asthma control and change in asthma control which occurs either spontaneously or as a result of treatment. Scores range between 0 (totally controlled) and 6 (severely uncontrolled) Baseline, 6 weeks later and 6 weeks after training
Secondary Change in quality of life Asthma Quality of Life Questionnaire is a disease-specific health-related quality of life instrument that taps both physical and emotional impact of disease. Scores range 1-7, with higher scores indicating better quality of life. Baseline, 6 weeks later and 6 weeks after training
Secondary Change in six minute walk test distance Six-minute walk test (6MWT) Baseline, 6 weeks later and 6 weeks after training
Secondary Change in forced vital capacity Forced vital capacity in litres and % of predicted Baseline, 6 weeks later and 6 weeks after training
Secondary Change in forced expiratory volume Forced expiratory volume in litres and % of predicted Baseline, 6 weeks later and 6 weeks after training
Secondary Change in forced expiratory volume/forced vital capacity Forced expiratory volume/forced vital capacity Baseline, 6 weeks later and 6 weeks after training
Secondary Change in inspiratory muscle activity Surface electromyography of inspiratory muscles Baseline, 6 weeks later and 6 weeks after training
See also
  Status Clinical Trial Phase
Completed NCT04624425 - Additional Effects of Segmental Breathing In Asthma N/A
Terminated NCT04410523 - Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma Phase 2
Active, not recruiting NCT03927820 - A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR) N/A
Completed NCT04617015 - Defining and Treating Depression-related Asthma Early Phase 1
Recruiting NCT03694158 - Investigating Dupilumab's Effect in Asthma by Genotype Phase 4
Terminated NCT04946318 - Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma Phase 2
Completed NCT04450108 - Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients N/A
Completed NCT03086460 - A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH) Phase 2
Completed NCT01160224 - Oral GW766944 (Oral CCR3 Antagonist) Phase 2
Completed NCT03186209 - Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE) Phase 3
Completed NCT02502734 - Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma Phase 3
Completed NCT01715844 - L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics Phase 1
Terminated NCT04993443 - First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036 Phase 1
Completed NCT02787863 - Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology Phase 4
Recruiting NCT06033833 - Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study Phase 2
Completed NCT03257995 - Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma. Phase 2
Completed NCT02212483 - Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients N/A
Recruiting NCT04872309 - MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
Withdrawn NCT01468805 - Childhood Asthma Reduction Study N/A
Recruiting NCT05145894 - Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device